88 related articles for article (PubMed ID: 2810796)
41. DNA-flow cytometry studies in blood and marrow cells from chronic myelogenous leukemia patients treated with interferon alpha-2b.
Wandl UB; May D; Peltzer T; Kloke O; Opalka B; Niederle N; Streffer C
Leuk Res; 1990; 14(10):905-8. PubMed ID: 2259227
[TBL] [Abstract][Full Text] [Related]
42. Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia.
Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():63. PubMed ID: 2496883
[No Abstract] [Full Text] [Related]
43. [The treatment of chronic myeloid leukemia in chronic phase with interferons].
Guilhot F
Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457
[No Abstract] [Full Text] [Related]
44. [Acute leukemia successfully treated with natural interferon-alpha].
Moriya K; Miura N; Sunaga S; Horie R; Aoki K; Yatomi Y; Yoneyama A; Higashihara M; Tanabe A; Nakahara K
Rinsho Ketsueki; 1991 Feb; 32(2):170-2. PubMed ID: 2027243
[TBL] [Abstract][Full Text] [Related]
45. Juvenile chronic myeloid leukaemia and alpha-interferon.
Aricò M; Nespoli L; Caselli D; Bonetti F; Porta FA; Burgio GR
Eur J Pediatr; 1989 Jan; 148(4):379-80. PubMed ID: 2707286
[No Abstract] [Full Text] [Related]
46. Elimination by interferon-alpha of malignant clone in chronic myeloid leukaemia.
Opalka B; Kloke O; Bartram CR; Beer U; Janssen JW; Niederle N; Wandl UB
Lancet; 1989 Jun; 1(8650):1334. PubMed ID: 2566865
[No Abstract] [Full Text] [Related]
47. Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia.
Schilling PJ; Kurzrock R; Kantarjian H; Gutterman JU; Talpaz M
Cancer; 1991 Oct; 68(7):1536-7. PubMed ID: 1893353
[TBL] [Abstract][Full Text] [Related]
48. Gastrointestinal malignancies as a complication of chronic myeloid leukaemia.
Slade R; Thomas WE
Br J Clin Pract; 1990 Feb; 44(2):76-8. PubMed ID: 2383470
[TBL] [Abstract][Full Text] [Related]
49. [The trial use of alpha-IFN in treating a case of chronic myelomonocytic leukemia with splenic infarction].
Kimura S; Yokoo K; Ozawa M; Kobayashi Y; Horiuchi H; Kondo M
Gan No Rinsho; 1989 Apr; 35(5):615-9. PubMed ID: 2716192
[TBL] [Abstract][Full Text] [Related]
50. Predicting complete cytogenetic response in chronic myelogenous leukemia patients treated with recombinant interferon alpha.
Mahon FX; Montastruc M; Faberes C; Reiffers J
Blood; 1994 Nov; 84(10):3592-4. PubMed ID: 7832859
[No Abstract] [Full Text] [Related]
51. [Case report: rheumatoid arthritis complicated by chronic myelogenous leukemia treated with interferon].
Abe T; Imai K; Tokunoh T; Yawata A; Sasaki S; Hayashi T; Kurokawa S; Matsunaga T; Sakai H; Ishida T
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Feb; 18(1):70-5. PubMed ID: 7553041
[TBL] [Abstract][Full Text] [Related]
52. Hepatocellular carcinoma and bladder cancer as complications following five years of chemotherapy for acute myeloblastic leukemia.
Hirota Y; Matsumoto I; Aso T; Kondou S; Ikematsu W; Hino H; Nishiura S; Yoneda K; Shiraishi T
Jpn J Med; 1990; 29(2):203-7. PubMed ID: 2172608
[TBL] [Abstract][Full Text] [Related]
53. Anti-interferon antibodies in alpha interferon treated patients with chronic myeloid leukaemia.
Aitchison R; Allen P; Schey S; Newland AC
Br J Haematol; 1991 Jul; 78(3):465-7. PubMed ID: 1873235
[No Abstract] [Full Text] [Related]
54. Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia.
Wandl UB; Kloke O; Niederle N
Lancet; 1992 Jan; 339(8785):123-4. PubMed ID: 1345846
[No Abstract] [Full Text] [Related]
55. Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study.
Di Stasi SM; Virgili G; Vespasiani G; Porena M; Micali F
Br J Urol; 1993 Apr; 71(4):422-6. PubMed ID: 8499986
[TBL] [Abstract][Full Text] [Related]
56. Interferon in the treatment of chronic myeloid leukemia. Proceedings of a workshop. February 4-7, 1993, Flims, Switzerland.
Semin Hematol; 1993 Jul; 30(3 Suppl 3):1-54. PubMed ID: 8235695
[No Abstract] [Full Text] [Related]
57. [Multiple neoplasms: presentation of a new case].
Martín E; Castellsague J; Ordi J; López R; Saigi E; Mercade V
Rev Clin Esp; 1989; 185(3):168-9. PubMed ID: 2623232
[No Abstract] [Full Text] [Related]
58. Hypertrichosis of the eyelashes associated with interferon-alpha therapy for chronic granulocytic leukemia.
Berglund EF; Burton GV; Mills GM; Nichols GM
South Med J; 1990 Mar; 83(3):363. PubMed ID: 2315793
[No Abstract] [Full Text] [Related]
59. The activity of alpha interferons in chronic myelogenous leukemia.
Talpaz M
Am J Med Sci; 1988 Aug; 296(2):95-7. PubMed ID: 3165249
[No Abstract] [Full Text] [Related]
60. Transient acantholytic dermatosis in oncology patients.
Guana AL; Cohen PR
J Clin Oncol; 1994 Aug; 12(8):1703-9. PubMed ID: 8040681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
